VCM
CELG

Virtue Capital Management’s Celgene Corp CELG Stock Holding History

Virtue Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,197
Closed -$107K – 543
2018
Q1 		$107K Buy
1,197
+232
+24% +$22.3K 0.06% 226
2017
Q4 		$101K Buy
+965
New +$109K 0.06% 221

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtue Capital Management's CELG Position: Q2 2018 in Review

Virtue Capital Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 1,197 shares — an estimated $107K sold.

Virtue Capital Management first reported a position in CELG in Q4 2017 and held it in 2 quarters. The position peaked at $107K in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Virtue Capital Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Virtue Capital Management sold 1,197 Celgene Corp shares in Q2 2018, an estimated $107K.
  • Virtue Capital Management first reported a position in Celgene Corp in Q4 2017 and held it in 2 quarters.
  • Virtue Capital Management's Celgene Corp position peaked at $107K in Q1 2018.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Virtue Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.